Published in Cancer Weekly, August 4th, 2009
"CFSE assays and single-cell phospho-STAT-specific flow cytometry screening were used. T cells from advanced melanoma patients, in comparison with healthy donors, showed reduced...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.